We were pleased to present two complementary solutions designed for neurorehabilitation and early mobilization:

Lambda, our lower-limb rehabilitation robot, designed to support intensive, repetitive, and personalized training for patients.

PEDRO, an innovative solution for modern early mobilization, enabling mobilization, standing, and sensory stimulation directly at the patient’s bedside.

A big thank you to everyone who came to talk with us at the booth, test our devices, and share their insights on clinical needs in neurological rehabilitation.

These interactions confirm the importance of offering healthcare teams concrete, complementary solutions tailored to the patient’s rehabilitation journey—from the early phase through to functional retraining.

Thank you to the SIRN 2026 Congress for this wonderful event in Verona.

We’ll be exhibiting at the SIRN 2026 conference in Verona

We’ll be showcasing two complementary solutions for neurorehabilitation:
Lambda—our lower-limb rehabilitation robot
PEDRO — the most innovative solution for modern early mobilization: a multifunctional therapeutic device that enables mobilization, standing, and sensory stimulation, right at the patient’s bedside.

Two devices, one goal: to support clinical teams with practical, effective tools tailored to real-world settings.

📍 Verona | Booth 3–4

We’ll be at the SIRN 2026 congress!
The Lambda team looks forward to seeing you at our booth to discuss neurorehabilitation and introduce you to Lambda, our lower-limb rehabilitation robot.

📍 SIRN 2026 – Verona
🗓️ May 10–12, 2026
📌 Booth: 3-4

Lambda is thrilled to welcome Florian Hässig as a Strategic Advisor.
We look forward to drawing on his experience and network to support the company’s next phase of growth, accelerate our development, and strengthen our impact.

A few words from Florian :

" I am pleased to share that I have joined Lambda Health System as an advisor.

Based in Switzerland, the company develops innovative robotic solutions aimed at improving rehabilitation outcomes and making advanced therapies more accessible to patients and healthcare professionals.

In this new role, I will be working alongside the founders on key strategic and development topics, supporting the structuring and scaling of the company as it enters its next phase of growth.

A sincere thank you to Aurélien Fauquex and Yannick Charrotton for their trust and for the quality of our exchanges.

Looking forward to contributing to this exciting journey at the intersection of healthcare and innovation."